2
3. 12. 2021.
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug–drug interactions among HIV‐positive patients receiving treatment for coronavirus disease 2019 (COVID‐19)
The aim of this international multicentre study was to review potential drug–drug interactions (DDIs) for real‐life coadministration of combination antiretroviral therapy (cART) and coronavirus disease 2019 (COVID‐19)‐specific medications.